Originally Posted by
KenHamer
If you think this AE devaluation is in lieu of AC FF program cutbacks, I think you'll be in for a world of hurt.
Of course, even if you don't think that...
I am sure AC is studying the Turing Pharma case to see how they can increase extra fees by 5000 percent. It's a disgrace to shareholders that AC has been unable to figure this out and has to be shown by a 30 something kid on how it's done.